To understand the role of phospholipids on Cdr1p (drug exporter)-mediated drug resistance in yeast, the phospholipids biosynthesis genes PSD1, PSD2, CHO2, and OPI3 were deleted in a strain of Saccharomyces cerevisiae already overexpressing Cdr1-GFP of Candida albicans as a heterologous system. The effect of phospholipids biosynthesis gene deletion was analyzed on Cdr1p-GFP-mediated drug resistance as well as its localization. The results indicate that phospholipids biosynthesis disruption makes the cell sensitive to several drugs including fluconazole (FLC), with Δpsd1/Cdr1-GFP being worst affected. Interestingly, unlike sterols and sphingolipids, the localization of Cdr1p was unaffected by phospholipid biosynthesis gene disruption. Concomitantly, phospholipids mutants also showed an increase in reactive oxygen species (ROS) generation, as verified by fluorescence probe 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) method. In addition, the sensitivity of phospholipid mutants with FLC was found to be synergistic to ROS generation, resulting in further reduction of growth. Thus, this study proposes phospholipid biosynthesis as a novel target for antifungal therapy.

Amity Institute of Biotechnology Amity University Gurugram Haryana India

Department of Biochemistry Maharshi Dayanand University Rohtak Haryana India

Zobrazit více v PubMed

Antimicrob Agents Chemother. 2002 Dec;46(12):3695-705 PubMed

Med Mycol. 2005 Jun;43(4):285-318 PubMed

J Cell Sci. 2004 Dec 1;117(Pt 25):6031-41 PubMed

J Infect Dis. 2017 Aug 15;216(suppl_3):S431-S435 PubMed

J Biol Chem. 2000 Dec 1;275(48):37347-56 PubMed

Front Microbiol. 2017 Jan 12;7:2173 PubMed

J Biol Chem. 2000 Jan 21;275(3):2191-8 PubMed

Antimicrob Agents Chemother. 2005 Aug;49(8):3442-52 PubMed

Biochem Soc Trans. 2005 Nov;33(Pt 5):1219-23 PubMed

Mol Microbiol. 2010 Mar;75(5):1112-32 PubMed

Annu Rev Biochem. 2011;80:859-83 PubMed

Antimicrob Agents Chemother. 2009 Apr;53(4):1344-52 PubMed

Mol Cell Biol. 2008 Oct;28(19):5851-64 PubMed

J Lipid Res. 2009 Apr;50 Suppl:S69-73 PubMed

Jpn J Infect Dis. 2005 Feb;58(1):1-7 PubMed

Mol Biol Cell. 2016 Jul 15;27(14):2161-71 PubMed

Antimicrob Agents Chemother. 2008 Feb;52(2):694-704 PubMed

Biochim Biophys Acta. 2009 Mar;1788(3):743-52 PubMed

FEMS Microbiol Lett. 2000 Apr 1;185(1):59-63 PubMed

Biochim Biophys Acta Biomembr. 2018 Nov;1860(11):2308-2319 PubMed

Eukaryot Cell. 2003 Dec;2(6):1361-75 PubMed

J Biol Chem. 2001 Sep 7;276(36):33540-6 PubMed

Yeast. 1995 Apr 15;11(4):355-60 PubMed

Biochim Biophys Acta. 2005 Jun 1;1711(1):87-95 PubMed

Yeast. 2001 Feb;18(3):251-60 PubMed

Eukaryot Cell. 2011 Nov;10(11):1376-83 PubMed

Eukaryot Cell. 2011 Feb;10(2):187-97 PubMed

Mol Microbiol. 1997 Nov;26(3):481-91 PubMed

Antimicrob Agents Chemother. 2003 Aug;47(8):2404-12 PubMed

J Mol Biol. 2012 Nov 9;423(5):677-86 PubMed

Eukaryot Cell. 2004 Jun;3(3):675-84 PubMed

FEBS Open Bio. 2014 Jan 06;4:77-89 PubMed

Prog Lipid Res. 2016 Jan;61:63-72 PubMed

Free Radic Res. 2007 Nov;41(11):1212-23 PubMed

Antimicrob Agents Chemother. 2004 May;48(5):1788-96 PubMed

J Antimicrob Chemother. 1999 Jul;44(1):27-31 PubMed

Antimicrob Agents Chemother. 2003 May;47(5):1543-54 PubMed

PLoS One. 2013 Oct 11;8(10):e77380 PubMed

OMICS. 2013 Feb;17(2):84-93 PubMed

J Antimicrob Chemother. 2005 Jun;55(6):905-13 PubMed

PLoS One. 2011 Apr 29;6(4):e19266 PubMed

J Gen Microbiol. 1986 Sep;132(9):2421-31 PubMed

Annu Rev Microbiol. 2017 Sep 8;71:753-775 PubMed

Biochim Biophys Acta. 2002 Aug 19;1564(1):9-13 PubMed

Eukaryot Cell. 2015 Dec;14(12):1154-64 PubMed

Genetics. 2012 Feb;190(2):317-49 PubMed

J Biol Chem. 2012 Nov 23;287(48):40131-9 PubMed

Front Oncol. 2012 Oct 10;2:140 PubMed

PLoS One. 2012;7(6):e39812 PubMed